Drugs / Human umbilical cord mesenchymal stem cell injection
Human umbilical cord mesenchymal stem cell injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05468502 | Oct 2022 → Aug 2025 | idiopathic pulmonary fibrosis | Shanghai Life Science & Technology | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human umbilical cord mesenchymal stem cell injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05468502 ↗ |
| Modality | Cell therapy | “appropriate dose of cell therapy” NCT05468502 ↗ |
| Route | Other | “infused to the focus of patients with idiopathic pulmonary fibrosis through bronchoscope” NCT05468502 ↗ |